Aids Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	1987	Dermatological conditions in HIV infection.	+	-	nl	Br Med J (Clin Res Ed) 294(6563):29-32 (1987)
2	1986	The natural history of human T lymphotropic virus-III infection: the cause of AIDS.	+	-	nl	Br Med J (Clin Res Ed) 292(6512):5-12 (1986)
3	2003	Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.	+	-	nl	South Med J 96(2):180-8; quiz 189 (2003) Tanwani LK
4	2002	Primary human immunodeficiency virus.	+	-	nl	South Med J 95(11):1312-7 (2002) Taiwo BO
5	2001	Neurologic abnormalities in human immunodeficiency virus infection.	+	-	nl	South Med J 94(3):266-75 (2001)
6	1999	Manifestations of AIDS in the head and neck.	+	-	nl	South Med J 92(7):684-97 (1999)
7	1997	Psychiatric perspective of pediatric human immunodeficiency virus infection.	+	-	nl	South Med J 90(10):1007-16 (1997)
8	1994	Hypereosinophilic syndrome associated with HIV infection. Military Medical Consortium for Applied Retroviral Research.	+	-	nl	South Med J 87(4):525-9 (1994)
9	1994	HIV and pulmonary hypertension: a review.	+	-	nl	South Med J 87(3):357-62 (1994)
10	1989	Psychiatric manifestations of AIDS spectrum disorders.	+	-	nl	South Med J 82(3):352-7 (1989)
11	1988	Adrenal insufficiency in the acquired immunodeficiency syndrome.	+	-	nl	South Med J 81(12):1493-5 (1988)
12	2009	Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.	+	-	nl	Am J Infect Dis 5(3):231-258 (2009) Irish BP
13	2007	Predictors of disease progression in HIV infection: a review.	+	-	nl	AIDS Res Ther 4():11 (2007) Langford SE
14	2007	Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.	+	-	nl	AIDS Res Ther 4():9 (2007) Murdoch DM
15	1997	Pathology of acquired immunodeficiency syndrome.	+	-	nl	J Korean Med Sci 12(3):171-84 (1997)
16	2009	New options in the treatment of lipid disorders in HIV-infected patients.	+	-	nl	Open AIDS J 3():31-7 (2009) da Silva EF
17	1989	Hematologic abnormalities in patients with the acquired immunodeficiency syndrome. A controlled study and brief review of literature.	+	-	nl	J Med 20(3-4):177-92 (1989)
18	2009	LIPODYSTROPHY SYNDROME IN HIV-INFECTED CHILDREN ON HAART.	+	-	nl	South Afr J HIV Med 10(4):76-80 (2009) Innes S
19	2000	Cardiac manifestations of acquired immunodeficiency syndrome.	+	-	nl	Arch Intern Med 160(5):602-8 (2000)
20	1999	Think HIV: why physicians should lower their threshold for HIV testing.	+	-	nl	Arch Intern Med 159(17):1994-2000 (1999)
21	2008	The first postmodern pandemic: 25 years of HIV/ AIDS.	+	-	nl	J Intern Med 263(3):218-43 (2008) Kallings LO
22	1993	Acquired immunodeficiency syndrome--a review and update. History, characteristics of human immunodeficiency virus infection, its replication, biologic factors, and pathogenicity.	+	-	nl	Arch Fam Med 2(10):1068-77 (1993)
23	2001	Cardiovascular manifestations of HIV infection.	+	-	nl	J R Soc Med 94(8):384-90 (2001)
24	1987	Surgeon General's report on acquired immune deficiency syndrome.	+	-	nl	Public Health Rep 102(1):1-3 (1987)
25	1983	The science base underlying research on acquired immune deficiency syndrome.	+	-	nl	Public Health Rep 98(6):559-65 (1983)
26	1991	Do physicians have an ethical obligation to care for patients with AIDS?	+	-	nl	Yale J Biol Med 64(3):207-46 (1991)
27	1987	Neurology of AIDS virus infection: a clinical classification.	+	-	nl	Yale J Biol Med 60(6):537-43 (1987)
28	1982	The Acquired Immunodeficiency Syndrome: current status.	+	-	nl	Yale J Biol Med 55(5-6):443-52 (1982)
29	2003	Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia.	+	-	nl	J Neurochem 86(5):1057-71 (2003) Saha RN
30	2007	HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.	+	-	nl	J Neurochem 100(3):567-86 (2007) Hauser KF
31	2005	Rodent model systems for studies of HIV-1 associated dementia.	+	-	nl	Neurotox Res 8(1-2):91-106 (2005) Persidsky Y
32	2005	The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies.	+	-	nl	Neurotox Res 8(1-2):3-24 (2005) Navia BA
33	2005	Involvement of quinolinic acid in AIDS dementia complex.	+	-	nl	Neurotox Res 7(1-2):103-23 (2005) Guillemin GJ
34	2004	Neuroprotective strategies for HIV-1 associated dementia.	+	-	nl	Neurotox Res 6(7-8):503-21 (2004) Dou H
35	1992	Pain syndromes in HIV infection.	+	-	nl	Can J Anaesth 39(7):724-30 (1992)
36	2001	The expanding role of the cardiologist in the care of HIV infected patients.	+	-	nl	Heart 86(4):365-7 (2001)
37	2006	Antiretroviral therapy 2006: pharmacology, applications, and special situations.	+	-	nl	Arch Pharm Res 29(6):431-58 (2006) Samuel R
38	2006	Successful HIV treatment: lessons learned.	+	-	nl	J Manag Care Pharm 12(7 Suppl B):S6-11 (2006) Cohen CJ
39	2010	CCR5 antagonists: host-targeted antiviral agents for the treatment of HIV infection, 4 years on.	+	-	nl	Antivir Chem Chemother 20(5):179-92 (2010) Westby M
40	2009	Elvitegravir: a new HIV integrase inhibitor.	+	-	nl	Antivir Chem Chemother 20(2):79-85 (2009) Shimura K
41	2009	Antiretroviral therapy in macrophages: implication for HIV eradication.	+	-	nl	Antivir Chem Chemother 20(2):63-78 (2009) Gavegnano C
42	2009	Current peptide HIV type-1 fusion inhibitors.	+	-	nl	Antivir Chem Chemother 20(1):1-18 (2009) Pang W
43	2009	RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside.	+	-	nl	Antivir Chem Chemother 19(6):221-33 (2009) von Eije KJ
44	2009	Novel compounds for the treatment of HIV type-1 infection.	+	-	nl	Antivir Chem Chemother 19(5):189-200 (2009) Stellbrink HJ
45	2009	HIV type-1 latency: targeted induction of proviral reservoirs.	+	-	nl	Antivir Chem Chemother 19(5):177-87 (2009) Graci JD
46	2008	Bevirimat: a novel maturation inhibitor for the treatment of HIV-1 infection.	+	-	nl	Antivir Chem Chemother 19(3):107-13 (2008) Martin DE
47	2007	Apricitabine: a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infection.	+	-	nl	Antivir Chem Chemother 18(2):61-70 (2007) Wainberg MA
48	2005	CCR5 antagonists: host-targeted antivirals for the treatment of HIV infection.	+	-	nl	Antivir Chem Chemother 16(6):339-54 (2005) Westby M
49	2004	Clinical utility of current NNRTIs and perspectives of new agents in this class under development.	+	-	nl	Antivir Chem Chemother 15(3):121-34 (2004) Zhang Z
50	2004	Gene silencing of HIV-1 by RNA interference.	+	-	nl	Antivir Chem Chemother 15(2):57-65 (2004) Takaku H
51	2001	Cytokines and HIV-1: interactions and clinical implications.	+	-	nl	Antivir Chem Chemother 12(3):133-50 (2001)
52	2001	Structural studies of chemokines that inhibit HIV-1 entry.	+	-	nl	Antivir Chem Chemother 12 Suppl 1(-):43-9 (2001)
53	1999	Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom.	+	-	nl	Antivir Chem Chemother 10(6):285-314 (1999)
54	1999	Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target.	+	-	nl	Antivir Chem Chemother 10(2):53-62 (1999)
55	1999	Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy.	+	-	nl	Antivir Chem Chemother 10(1):1-14 (1999)
56	2010	Etravirine: clinical review of a treatment option for HIV type-1-infected patients with non-nucleoside reverse transcriptase inhibitor resistance.	+	-	nl	Antivir Ther 15(6):803-16 (2010) Towner WJ
57	2010	Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases.	+	-	nl	Antivir Ther 15(4):677-80 (2010) Jaworsky D
58	2009	Hypophosphataemia: an easy strategy for diagnosis and treatment in HIV patients.	+	-	nl	Antivir Ther 14(4):481-8 (2009) Bagnis CI
59	2007	Late presentation of HIV-infected individuals.	+	-	nl	Antivir Ther 12(6):841-51 (2007) Battegay M
60	2005	Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.	+	-	nl	Antivir Ther 10(1):29-40 (2005) Joly V
61	2004	Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.	+	-	nl	Antivir Ther 9(2):161-77 (2004) Gougeon ML
62	2003	Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance.	+	-	nl	Antivir Ther 8(6):489-506 (2003) Gallant JE
63	2003	Mitochondria and lipodystrophy: where are we now?	+	-	nl	Antivir Ther 8(4):261-3 (2003) Gerschenson M
64	2001	Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis.	+	-	nl	Antivir Ther 6(3):145-60 (2001)
65	2001	Antiretroviral therapy and the lipodystrophy syndrome.	+	-	nl	Antivir Ther 6(1):9-20 (2001) John M
66	1999	Pharmacology of antiretroviral drugs.	+	-	nl	Antivir Ther 4 Suppl 3(-):29-41 (1999)
67	2008	European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.	+	-	nl	HIV Med 9(2):82-8 (2008) Rockstroh JK
68	2008	European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.	+	-	nl	HIV Med 9(2):72-81 (2008) Lundgren JD
69	2008	European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults.	+	-	nl	HIV Med 9(2):65-71 (2008) Clumeck N
70	2007	The management of dyslipidaemias in antiretroviral-treated HIV infection: a systematic review.	+	-	nl	HIV Med 8(6):325-34 (2007) McGoldrick C
71	2007	Once-daily nevirapine dosing: a pharmacokinetics, efficacy and safety review.	+	-	nl	HIV Med 8(1):1-7 (2007) Cooper CL
72	2006	Counteracting muscle wasting in HIV-infected individuals.	+	-	nl	HIV Med 7(5):299-310 (2006) Dudgeon WD
73	2005	Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.	+	-	nl	HIV Med 6 Suppl 2():107-48 (2005) Hawkins D
74	2005	Guidelines for liver transplantation in patients with HIV infection (2005).	+	-	nl	HIV Med 6 Suppl 2():149-53 (2005) O'Grady J
75	2005	BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005).	+	-	nl	HIV Med 6 Suppl 2():96-106 (2005) Nelson M
76	2005	BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis B virus infection (2005).	+	-	nl	HIV Med 6 Suppl 2():84-95 (2005) Brook MG
77	2005	BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.	+	-	nl	HIV Med 6 Suppl 2():62-83 (2005) Pozniak AL
78	2005	British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).	+	-	nl	HIV Med 6 Suppl 2():1-61 (2005) Gazzard B
79	2005	New drugs.	+	-	nl	HIV Med 6(4):225-31 (2005) Waters L
80	2005	Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.	+	-	nl	HIV Med 6(2):66-78 (2005) Torre D
81	2004	Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE) therapy in Thailand.	+	-	nl	HIV Med 5(5):317-25 (2004) Chantratita W
82	2004	PENTA guidelines for the use of antiretroviral therapy, 2004.	+	-	nl	HIV Med 5 Suppl 2():61-86 (2004) Sharland M
83	2001	HIV-associated lipodystrophy.	+	-	nl	HIV Med 2(3):166-73 (2001)
84	2008	The role of HIV in serious diseases other than AIDS.	+	-	nl	AIDS 22(18):2409-18 (2008)
85	2008	Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.	+	-	nl	AIDS 22(17):2279-89 (2008) Fox Z
86	2008	A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.	+	-	nl	AIDS 22(15):1909-17 (2008) Wira CR
87	2008	HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.	+	-	nl	AIDS Rev 10(2):67-84 (2008) Shafer RW
88	2003	HIV sequence databases.	+	-	nl	AIDS Rev 5(1):52-61 (2003) Kuiken C
89	2000	The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.	+	-	nl	AIDS Rev 2(4):211-228 (2000) Shafer RW
90	2010	The macrophage in HIV-1 infection: from activation to deactivation?	+	-	nl	Retrovirology 7():33 (2010) Herbein G
91	2010	Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.	+	-	nl	Retrovirology 7():32 (2010) Le Douce V
92	2010	Journey to the heart of macrophages: the delicate relationship between HIV-1 and a multifaceted cell type.	+	-	nl	Retrovirology 7():28 (2010) Cimarelli A
93	2009	Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.	+	-	nl	Retrovirology 6():118 (2009) Kilareski EM
94	2009	On the steps of cell-to-cell HIV transmission between CD4 T cells.	+	-	nl	Retrovirology 6():89 (2009) Puigdomenech I
95	2009	HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.	+	-	nl	Retrovirology 6():51 (2009) Coleman CM
96	2009	Raltegravir, elvitegravir, and metoogravir: the birth of 'me-too' HIV-1 integrase inhibitors.	+	-	nl	Retrovirology 6():25 (2009) Serrao E
97	2006	HIV-1 associated dementia: symptoms and causes.	+	-	nl	Retrovirology 3():28 (2006) Ghafouri M
98	2010	Abacavir/lamivudine combination in the treatment of HIV: a review.	+	-	nl	Ther Clin Risk Manag 6():83-94 (2010) Sivasubramanian G
99	2009	Pharmacotherapy of pediatric and adolescent HIV infection.	+	-	nl	Ther Clin Risk Manag 5(3):469-84 (2009) Schuval SJ
100	2008	Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naive patients.	+	-	nl	Ther Clin Risk Manag 4(6):1281-4 (2008) Flamholc L
101	2008	Lopinavir/ritonavir in the treatment of HIV-1 infection: a review.	+	-	nl	Ther Clin Risk Manag 4(5):1023-33 (2008) Chandwani A
102	2008	New approaches in the treatment of HIV/AIDS - focus on maraviroc and other CCR5 antagonists.	+	-	nl	Ther Clin Risk Manag 4(2):473-85 (2008) Schlecht HP
103	2010	Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection.	+	-	nl	Core Evid 4():149-58 (2010) Stellbrink HJ
104	2010	Raltegravir: The evidence of its therapeutic value in HIV-1 infection.	+	-	nl	Core Evid 4():131-47 (2010) Ramkumar K
105	2000	The United States in 1981: the appearance of AIDS.	+	-	nl	Eur J Dermatol 10(3):242 (2000)
106	2009	Antiretroviral drug resistance in human immunodeficiency virus type 2.	+	-	nl	Antimicrob Agents Chemother 53(9):3611-9 (2009) Ntemgwa ML
107	1992	Antiretroviral therapy: reverse transcriptase inhibition.	+	-	nl	Antimicrob Agents Chemother 36(2):245-54 (1992)
108	2009	Evolving perspectives on HIV-associated lipodystrophy syndrome: moving from lipodystrophy to non-infectious HIV co-morbidities.	+	-	nl	J Antimicrob Chemother 64(3):437-40 (2009) Guaraldi G
109	2008	Current perspectives on the management and prevention of antiretroviral-associated lipoatrophy.	+	-	nl	J Antimicrob Chemother 62(5):866-71 (2008) Phillips DR
110	2008	HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.	+	-	nl	J Antimicrob Chemother 62(4):648-60 (2008) Mallewa JE
111	2006	HIV entry inhibitors: mechanisms of action and resistance pathways.	+	-	nl	J Antimicrob Chemother 57(4):619-27 (2006) Briz V
112	2005	Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs.	+	-	nl	J Antimicrob Chemother 56(2):270-2 (2005) Vermeire K
113	2004	The intracellular pharmacology of antiretroviral protease inhibitors.	+	-	nl	J Antimicrob Chemother 54(6):982-90 (2004) Ford J
114	2004	A long-term latent reservoir for HIV-1: discovery and clinical implications.	+	-	nl	J Antimicrob Chemother 54(1):6-9 (2004) Siliciano JD
115	2004	Starting highly active antiretroviral therapy: why, when and response to HAART.	+	-	nl	J Antimicrob Chemother 54(1):10-3 (2004) Mocroft A
116	2004	Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients.	+	-	nl	J Antimicrob Chemother 53(1):4-9 (2004) Zeldin RK
117	2003	How does HAART lead to the resolution of Kaposi's sarcoma?	+	-	nl	J Antimicrob Chemother 51(5):1095-8 (2003) Stebbing J
118	2003	Treatment of advanced HIV infection.	+	-	nl	J Antimicrob Chemother 51(2):225-7 (2003) Pulido F
119	2003	Stopping HIV fusion with enfuvirtide: the first step to extracellular HAART.	+	-	nl	J Antimicrob Chemother 51(2):213-7 (2003) Moyle G
120	2003	HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity.	+	-	nl	J Antimicrob Chemother 51(2):207-11 (2003) Monini P
121	1996	Non-HIV AIDS: nature and strategies for its management.	+	-	nl	J Antimicrob Chemother 37 Suppl B(-):171-83 (1996)
122	1996	Surrogate markers in HIV disease.	+	-	nl	J Antimicrob Chemother 37 Suppl B(-):161-70 (1996)
123	1996	Management of malignancy in HIV infection.	+	-	nl	J Antimicrob Chemother 37 Suppl B(-):121-33 (1996)
124	1996	Mycobacteriosis and HIV infection: the new public health challenge.	+	-	nl	J Antimicrob Chemother 37 Suppl B(-):113-20 (1996)
125	1996	Antivirals in the context of HIV disease.	+	-	nl	J Antimicrob Chemother 37 Suppl B(-):97-112 (1996)
126	1996	Herpesviruses and AIDS.	+	-	nl	J Antimicrob Chemother 37 Suppl B(-):87-95 (1996)
127	1996	Treatment of fungal infection in AIDS.	+	-	nl	J Antimicrob Chemother 37 Suppl B(-):71-85 (1996)
128	1996	Recently recognised microbial enteropathies and HIV infection.	+	-	nl	J Antimicrob Chemother 37 Suppl B(-):61-70 (1996)
129	1996	Adverse reactions to co-trimoxazole in HIV infection: a reappraisal of the glutathione-hydroxylamine hypothesis.	+	-	nl	J Antimicrob Chemother 37 Suppl B(-):55-60 (1996)
130	1996	The immunopathology of HIV infection.	+	-	nl	J Antimicrob Chemother 37 Suppl B(-):13-25 (1996)
131	2006	Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways.	+	-	nl	Microbiol Mol Biol Rev 70(2):548-63 (2006) Roeth JF
132	2000	Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.	+	-	nl	Microbiol Mol Biol Rev 64(4):725-45 (2000)
133	1996	Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.	+	-	nl	Microbiol Rev 60(2):386-406 (1996) Chirmule N
134	1995	The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.	+	-	nl	Microbiol Rev 59(1):63-93 (1995)
135	1993	Pathogenesis of human immunodeficiency virus infection.	+	-	nl	Microbiol Rev 57(1):183-289 (1993)
136	1991	Genetic regulation of human immunodeficiency virus.	+	-	nl	Microbiol Rev 55(2):193-205 (1991)
137	1998	Protease inhibitors as antiviral agents.	+	-	nl	Clin Microbiol Rev 11(4):614-27 (1998)
138	1997	Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.	+	-	nl	Clin Microbiol Rev 10(2):358-67 (1997)
139	1996	Pediatric human immunodeficiency virus infection.	+	-	nl	Clin Microbiol Rev 9(4):448-68 (1996)
140	1996	Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.	+	-	nl	Clin Microbiol Rev 9(2):135-47 (1996)
141	1995	Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus.	+	-	nl	Clin Microbiol Rev 8(3):440-50 (1995)
142	1993	Human immunodeficiency virus type 1 infection of the brain.	+	-	nl	Clin Microbiol Rev 6(4):339-66 (1993)
143	1992	Laboratory methods for early detection of human immunodeficiency virus type 1 in newborns and infants.	+	-	nl	Clin Microbiol Rev 5(3):238-47 (1992)
144	1995	Antiviral therapy for human immunodeficiency virus infections.	+	-	nl	Clin Microbiol Rev 8(2):200-39 (1995)
145	1994	Markers predicting progression of human immunodeficiency virus-related disease.	+	-	nl	Clin Microbiol Rev 7(1):14-28 (1994)
146	1989	Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.	+	-	nl	Clin Microbiol Rev 2(4):360-77 (1989)
147	1989	Antigen detection for human immunodeficiency virus.	+	-	nl	Clin Microbiol Rev 2(3):241-9 (1989)
148	1988	Practical diagnostic testing for human immunodeficiency virus.	+	-	nl	Clin Microbiol Rev 1(1):124-38 (1988)
149	2004	Tuberculosis in HIV-infected patients: a comprehensive review.	+	-	nl	Clin Microbiol Infect 10(5):388-98 (2004) Aaron L
150	2003	Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS.	+	-	nl	J Gen Virol 84(Pt 7):1649-61 (2003) Alimonti JB
151	2002	Human immunodeficiency virus type 2.	+	-	nl	J Gen Virol 83(Pt 6):1253-65 (2002)
152	1998	Studies of viral co-factors for human immunodeficiency virus in vitro and in vivo.	+	-	nl	J Gen Virol 79 ( Pt 2)(-):213-20 (1998)
153	2007	Cytopathic mechanisms of HIV-1.	+	-	nl	Virol J 4():100 (2007) Costin JM
154	2001	Mitochondrial toxicity and HIV therapy.	+	-	nl	Sex Transm Infect 77(3):158-73 (2001)
155	2005	HIV-associated lipodystrophy syndrome: A review of clinical aspects.	+	-	nl	Can J Infect Dis Med Microbiol 16(4):233-43 (2005) Baril JG
156	2006	Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis.	+	-	nl	Clin Vaccine Immunol 13(7):715-21 (2006) Finzi D
157	2000	Infections in AIDS.	+	-	nl	J Med Microbiol 49(11):947-67 (2000)
158	1999	Current concepts in human immunodeficiency virus infection and AIDS.	+	-	nl	Clin Diagn Lab Immunol 6(3):295-305 (1999)
159	1999	Interactions of HIV-1 with antigen-presenting cells.	+	-	nl	Immunol Cell Biol 77(4):289-303 (1999)
160	1992	Diversity and variation in human immunodeficiency virus: implications for immune control.	+	-	nl	Immunol Cell Biol 70 ( Pt 3)(-):215-21 (1992)
161	2010	The good and evil of complement activation in HIV-1 infection.	+	-	nl	Cell Mol Immunol 7(5):334-40 (2010) Yu Q
162	2007	Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.	+	-	nl	Immunity 27(3):406-16 (2007) Deeks SG
163	2002	Live and let die: Nef functions beyond HIV replication.	+	-	nl	Immunity 16(4):493-7 (2002)
164	2001	Resistance is futile: assimilation of cellular machinery by HIV-1.	+	-	nl	Immunity 15(5):687-90 (2001)
165	1998	HIV-induced immunopathogenesis.	+	-	nl	Immunity 9(5):587-93 (1998)
166	1998	HIV nef: the mother of all evil?	+	-	nl	Immunity 9(4):433-7 (1998)
167	1997	T cell turnover in HIV-1 disease.	+	-	nl	Immunity 7(5):583-9 (1997)
168	2008	Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.	+	-	nl	J Leukoc Biol 84(1):27-49 (2008) Iannello A
169	2008	Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.	+	-	nl	J Leukoc Biol 84(1):1-26 (2008) Iannello A
170	2006	Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence.	+	-	nl	J Leukoc Biol 80(5):1018-30 (2006) Cassol E
171	2006	Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.	+	-	nl	J Leukoc Biol 80(5):1103-10 (2006) Aquaro S
172	2006	HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes.	+	-	nl	J Leukoc Biol 80(5):965-72 (2006) Goodenow MM
173	2006	HIV interactions with dendritic cells: has our focus been too narrow?	+	-	nl	J Leukoc Biol 80(5):1001-12 (2006) Donaghy H
174	2006	HIV regulation of the IL-7R: a viral mechanism for enhancing HIV-1 replication in human macrophages in vitro.	+	-	nl	J Leukoc Biol 79(6):1328-38 (2006) Zhang M
175	2003	Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection.	+	-	nl	J Leukoc Biol 74(5):691-701 (2003) Persidsky Y
176	2003	Immunodeficiency virus exploitation of dendritic cells in the early steps of infection.	+	-	nl	J Leukoc Biol 74(5):683-90 (2003) Teleshova N
177	2003	Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells.	+	-	nl	J Leukoc Biol 74(5):736-49 (2003) Rohr O
178	2003	The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection.	+	-	nl	J Leukoc Biol 74(5):635-41 (2003) Crowe S
179	2003	The role of dendritic cell C-type lectin receptors in HIV pathogenesis.	+	-	nl	J Leukoc Biol 74(5):710-8 (2003) Turville S
180	2003	Macrophage HIV-1 infection and the gastrointestinal tract reservoir.	+	-	nl	J Leukoc Biol 74(5):642-9 (2003) Smith PD
181	2003	Viral and host cofactors facilitate HIV-1 replication in macrophages.	+	-	nl	J Leukoc Biol 74(5):726-35 (2003) Wahl SM
182	1999	Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat.	+	-	nl	J Leukoc Biol 65(4):458-65 (1999)
183	1997	Immunosuppressive retroviral peptides: immunopathological implications for immunosuppressive influences of retroviral infections.	+	-	nl	J Leukoc Biol 61(6):654-66 (1997)
184	1994	Biology of the mononuclear phagocyte system of the central nervous system and HIV infection.	+	-	nl	J Leukoc Biol 56(3):399-406 (1994) Perry VH
185	1994	The neuropathogenesis of HIV-1 infection.	+	-	nl	J Leukoc Biol 56(3):389-98 (1994) Gendelman HE
186	1994	Macrophages/microglia and the pathophysiology of CNS injuries in AIDS.	+	-	nl	J Leukoc Biol 56(3):387-8 (1994)
187	1988	Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS).	+	-	nl	J Leukoc Biol 43(1):91-7 (1988)
188	2008	25 years of HIV research on virology, virus restriction, immunopathogenesis, genes and vaccines.	+	-	nl	Clin Exp Immunol 154(1):6-14 (2008) Scherer E
189	2008	Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges.	+	-	nl	Clin Exp Immunol 152(2):201-10 (2008) Weiss RA
190	1984	The acquired immune deficiency syndrome.	+	-	nl	Clin Exp Immunol 56(1):1-13 (1984)
191	2009	What we still don't know about AIDS.	+	-	nl	J Biol 8(10):87 (2009) Robertson M
192	2005	Molecular mechanisms of HIV-1 associated neurodegeneration.	+	-	nl	J Biosci 30(3):391-405 (2005) Ozdener H
193	2003	HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.	+	-	nl	J Biosci 28(3):323-35 (2003) Greenway AL
194	2005	AIDS and associated malignancies.	+	-	nl	Cell Res 15(11-12):947-52 (2005) Wood C
195	2003	New insights into the immunology and evolution of HIV.	+	-	nl	Cell Res 13(1):1-7 (2003) Stebbing J
196	2001	The burden of proof and the origin of acquired immune deficiency syndrome.	+	-	nl	Philos Trans R Soc Lond B Biol Sci 356(1410):939-43 (2001)
197	2001	The origin of acquired immune deficiency syndrome: Can science afford to ignore it?	+	-	nl	Philos Trans R Soc Lond B Biol Sci 356(1410):935-8 (2001)
198	2001	The earliest cases of human immunodeficiency virus type 1 group M in Congo-Kinshasa, Rwanda and Burundi and the origin of acquired immune deficiency syndrome.	+	-	nl	Philos Trans R Soc Lond B Biol Sci 356(1410):923-5 (2001)
199	2001	The origins of acquired immune deficiency syndrome viruses: where and when?	+	-	nl	Philos Trans R Soc Lond B Biol Sci 356(1410):867-76 (2001)
200	2001	Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution.	+	-	nl	Philos Trans R Soc Lond B Biol Sci 356(1410):855-66 (2001)
201	2001	Polio vaccine and retroviruses.	+	-	nl	Philos Trans R Soc Lond B Biol Sci 356(1410):841-3 (2001)
202	2001	Experimental oral polio vaccines and acquired immune deficiency syndrome.	+	-	nl	Philos Trans R Soc Lond B Biol Sci 356(1410):803-14 (2001)
203	2007	Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator.	+	-	nl	Indian J Biochem Biophys 44(5):269-75 (2007) Gupta S
204	2006	Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists.	+	-	nl	Clin J Am Soc Nephrol 1(1):117-29 (2006) Berns JS
205	1993	The pathogenesis of the neurological complications of HIV-1 infection.	+	-	nl	Genitourin Med 69(5):333-40 (1993)
206	1991	Clinical, virological and immunological features of primary HIV-1 infection.	+	-	nl	Genitourin Med 67(5):367-73 (1991)
207	1999	Neoplastic complications of HIV infection.	+	-	nl	Ann Oncol 10(11):1271-86 (1999)
208	2005	Recent advances in acquired immunodeficiency syndrome (AIDS)-related lymphoma.	+	-	nl	CA Cancer J Clin 55(4):229-41; 260-1, 264 (2005) Lim ST
209	1992	Malignant neoplasms associated with human immunodeficiency virus infection.	+	-	nl	CA Cancer J Clin 42(2):74-95 (1992)
210	2004	Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.	+	-	nl	Cancer 100(12):2627-36 (2004) Newell ME
211	1999	Cancers in children infected with the human immunodeficiency virus.	+	-	nl	Oncologist 4(4):309-17 (1999)
212	1990	Immunopathogenesis of human immunodeficiency virus infection.	+	-	nl	Cancer Res 50(17 Suppl):5612S-5617S (1990)
213	1995	Identifying and treating HIV-related oral conditions: a clinical grand rounds approach.	+	-	nl	J Am Dent Assoc 126(10):1394-400 (1995)
214	1994	HIV-related tumors of the oral cavity.	+	-	nl	Crit Rev Oral Biol Med 5(2):159-85 (1994)
215	1993	HIV in the oral cavity: virus, viral inhibitory activity, and antiviral antibodies: a review.	+	-	nl	Crit Rev Oral Biol Med 4(3-4):461-6 (1993)
216	1992	HIV-related infections of the oral cavity.	+	-	nl	Crit Rev Oral Biol Med 3(3):207-31 (1992)
217	1986	The neuropathology of AIDS. UCLA experience and review.	+	-	nl	Am J Pathol 124(3):537-58 (1986)
218	1983	Autopsy pathology in the acquired immune deficiency syndrome.	+	-	nl	Am J Pathol 112(3):357-82 (1983)
219	2006	Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.	+	-	nl	Ann Intern Med 145(6):397-406 (2006) Sackoff JE
220	1999	1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with Human Immunodeficiency Virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. Infectious Diseases Society of American.	+	-	nl	Ann Intern Med 131(11):873-908 (1999)
221	2006	AIDS-related lymphoproliferative disease.	+	-	nl	Blood 107(1):13-20 (2006) Navarro WH
222	2003	Human immunodeficiency virus hematology.	+	-	nl	Hematology Am Soc Hematol Educ Program ():294-313 (2003) Volberding PA
223	2001	Hematologic Aspects of HIV/AIDS.	+	-	nl	Hematology Am Soc Hematol Educ Program -(-):463-78 (2001)
224	1991	Opportunistic protozoan infections in human immunodeficiency virus disease: review highlighting diagnostic and therapeutic aspects.	+	-	nl	J Clin Pathol 44(3):182-93 (1991)
225	1988	Haematological abnormalities in human immunodeficiency virus (HIV) disease.	+	-	nl	J Clin Pathol 41(7):711-5 (1988)
226	1991	The AIDS virus. What we know and what we can do about it.	+	-	nl	West J Med 155(5):481-7 (1991)
227	1998	Pulmonary complications of HIV infection: autopsy findings.	+	-	nl	Chest 113(5):1225-9 (1998)
228	1997	AIDS-related airway disease.	+	-	nl	AJR Am J Roentgenol 168(1):67-77 (1997)
229	1989	Imaging of infants and children with AIDS.	+	-	nl	AJR Am J Roentgenol 152(5):1033-41 (1989)
230	1988	CNS complications of AIDS: CT and MR findings.	+	-	nl	AJR Am J Roentgenol 151(3):449-54 (1988)
231	1986	Neuroradiologic findings in AIDS: a review of 200 cases.	+	-	nl	AJR Am J Roentgenol 147(5):977-83 (1986)
232	1986	Abdominal CT in acquired immunodeficiency syndrome.	+	-	nl	AJR Am J Roentgenol 146(1):7-13 (1986)
233	1986	Multifocal abnormalities of the gastrointestinal tract in AIDS.	+	-	nl	AJR Am J Roentgenol 146(1):1-5 (1986)
234	1985	Cranial CT in acquired immunodeficiency syndrome: spectrum of diseases and optimal contrast enhancement technique.	+	-	nl	AJR Am J Roentgenol 145(5):929-40 (1985)
235	1989	The diagnostic role of nuclear medicine in the acquired immunodeficiency syndrome.	+	-	nl	J Nucl Med 30(12):1935-45 (1989)
236	1994	Acquired immunodeficiency syndrome and its ocular complications.	+	-	nl	Indian J Ophthalmol 42(2):51-63 (1994)
237	1988	Diagnosis and management of ocular lesions in acquired immune deficiency syndrome.	+	-	nl	Indian J Ophthalmol 36(4):151-5 (1988)
238	1995	Ocular manifestations of HIV infection.	+	-	nl	Trans Am Ophthalmol Soc 93(-):623-83 (1995)
239	1984	The retinal lesions of the acquired immune deficiency syndrome.	+	-	nl	Trans Am Ophthalmol Soc 82(-):447-91 (1984)
240	2008	From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation.	+	-	nl	Radiographics 28(7):2033-58 (2008)
241	2006	Cardiovascular complications of human immunodeficiency virus infection.	+	-	nl	Radiographics 26(1):213-31 (2006) Restrepo CS
242	2004	Imaging findings in musculoskeletal complications of AIDS.	+	-	nl	Radiographics 24(4):1029-49 (2004) Restrepo CS
243	2006	HIV-1 infection: is it time to reconsider our concepts?	+	-	nl	Int J Mol Med 18(1):3-8 (2006) Krambovitis E
244	1998	Functional roles of HIV accessory proteins for viral replication (review).	+	-	nl	Int J Mol Med 2(4):429-33 (1998)
245	2005	HTLV-1 Tax nucleocytoplasmic shuttling, interaction with the secretory pathway, extracellular signaling, and implications for neurologic disease.	+	-	nl	J Biomed Sci 12(6):961-74 (2005) Alefantis T
246	2001	Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat.	+	-	nl	J Biomed Sci 8(3):290-6 (2001)
247	1996	AIDS Dementia and HIV-1-Induced Neurotoxicity: Possible Pathogenic Associations and Mechanisms.	+	-	nl	J Biomed Sci 3(6):389-414 (1996) Kolson DL
248	2005	Neuropathology of HIV/AIDS with an overview of the Indian scene.	+	-	nl	Indian J Med Res 121(4):468-88 (2005) Shankar SK
249	2005	HIV & psychiatric disorders.	+	-	nl	Indian J Med Res 121(4):451-67 (2005) Chandra PS
250	2005	Molecular epidemiology of HIV.	+	-	nl	Indian J Med Res 121(4):333-44 (2005) Kandathil AJ
251	2005	Biology of the HIV Nef protein.	+	-	nl	Indian J Med Res 121(4):315-32 (2005) Das SR
252	2005	HIV-1 viral protein R (Vpr) & host cellular responses.	+	-	nl	Indian J Med Res 121(4):270-86 (2005) Zhao RY
253	2005	Immunopathogenesis of HIV infection.	+	-	nl	Indian J Med Res 121(4):240-55 (2005) Paranjape RS
254	2005	HAART & the molecular biology of AIDS dementia complex.	+	-	nl	Indian J Med Res 121(4):256-69 (2005) Saksena NK
255	1993	Why are there so many myths about AIDS?	+	-	nl	CMAJ 148(5):745-9 (1993)
256	1986	A guide to the investigation and treatment of patients with AIDS and AIDS-related disorders.	+	-	nl	CMAJ 134(9):999-1008 (1986)
257	1995	Gastrointestinal manifestations of acquired immunodeficiency syndrome: radiologic-pathologic correlation.	+	-	nl	Radiographics 15(5):1155-78 (1995)
258	1992	Diagnostic uses of nuclear medicine in AIDS.	+	-	nl	Radiographics 12(4):731-49; discussion 749-52 (1992)
259	1990	Acute abdomen in AIDS: CT diagnosis and triage.	+	-	nl	Radiographics 10(4):621-34 (1990)
260	1989	Diseases of the chest in AIDS: CT diagnosis.	+	-	nl	Radiographics 9(5):827-57 (1989)
261	2009	Brain: non-infective and non-neoplastic manifestations of HIV.	+	-	nl	Br J Radiol 82(983):956-65 (2009) Saravanan M
262	1988	White matter disease in AIDS: findings at MR imaging.	+	-	nl	Radiology 169(2):445-8 (1988)
263	1988	A radiologist looks at AIDS: imaging evaluation based on symptom complexes.	+	-	nl	Radiology 166(2):553-62 (1988)
264	1986	Pulmonary manifestations of AIDS: review of 106 episodes.	+	-	nl	Radiology 161(1):87-93 (1986)
265	1986	Gastrointestinal complications of AIDS: radiologic features.	+	-	nl	Radiology 158(3):597-603 (1986)
266	2005	Cerebral MR imaging in uninfected children born to HIV-seropositive mothers and perinatally exposed to zidovudine.	+	-	nl	AJNR Am J Neuroradiol 26(4):695-701 (2005) Tardieu M
267	2005	Perinatal exposure to antiretroviral agents: risks and benefits.	+	-	nl	AJNR Am J Neuroradiol 26(4):689-92 (2005) Scott GB
268	2005	A new challenge for the neuroradiologist: MR recognition of mitochondrial dysfunction in children born of HIV-seropositive mothers on antiretroviral therapy.	+	-	nl	AJNR Am J Neuroradiol 26(4):687-9 (2005) Post MJ
269	2003	Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphoma.	+	-	nl	AJNR Am J Neuroradiol 24(4):554-5 (2003) Berger JR
270	1999	AIDS-associated myelopathy: clinical severity, MR findings, and underlying etiologies.	+	-	nl	AJNR Am J Neuroradiol 20(8):1387-8 (1999)
271	2010	AIDS treatment with novel anti-HIV compounds improved by nanotechnology.	+	-	nl	AAPS J 12(3):272-8 (2010)
272	2008	A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections.	+	-	nl	AAPS PharmSciTech 9(2):505-20 (2008)
273	2008	The viral etiology of AIDS-associated malignancies.	+	-	nl	Adv Pharmacol 56(-):509-57 (2008)
274	2011	Management of HIV infection in treatment-naive patients: a review of the most current recommendations.	+	-	nl	Am J Health Syst Pharm 68(11):991-1001 (2011)
275	2011	HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia.	+	-	nl	Acta Myol 30(1):29-31 (2011)
276	2007	Oncogenic viruses in AIDS: mechanisms of disease and intrathoracic manifestations.	+	-	nl	AJR Am J Roentgenol 189(5):1082-7 (2007)
277	2004	Dialyzing a patient with human immunodeficiency virus infection: what a nephrologist needs to know.	+	-	nl	Am J Nephrol 24(5):511-21 (2004)
278	2010	The treatment of HIV-associated nephropathy.	+	-	nl	Adv Chronic Kidney Dis 17(1):59-71 (2010)
279	2010	Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene.	+	-	nl	Adv Chronic Kidney Dis 17(1):44-51 (2010)
280	2010	Screening for chronic kidney disease in HIV-infected patients.	+	-	nl	Adv Chronic Kidney Dis 17(1):26-35 (2010)
281	2011	The neurobiology of HIV dementia: implications for practice in South Africa.	+	-	nl	Afr J Psychiatry (Johannesbg) 14(1):17-22 (2011)
282	2002	Violence during pregnancy among women with or at risk for HIV infection.	+	-	nl	Am J Public Health 92(3):367-70 (2002)
283	2009	Review: the need for smoking cessation among HIV-positive smokers.	+	-	nl	AIDS Educ Prev 21(3 Suppl):14-27 (2009)
284	2009	Effect of cigarette smoking on HIV acquisition, progression, and mortality.	+	-	nl	AIDS Educ Prev 21(3 Suppl):28-39 (2009)
285	2009	Utilization of medical treatments and adherence to antiretroviral therapy among HIV-positive adults with histories of childhood sexual abuse.	+	-	nl	AIDS Patient Care STDS 23(4):259-66 (2009)
286	2009	Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review.	+	-	nl	AIDS Res Ther 6(-):25 (2009)
287	2011	Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.	+	-	nl	AIDS Res Treat 2011(-):463704 (2011)
288	2010	Virologic and immunologic response to HAART, by age and regimen class.	+	-	nl	AIDS 24(16):2469-79 (2010)
289	2009	Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities.	+	-	nl	AIDS 23(8):875-85 (2009)
290	2010	Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?	+	-	nl	Antiviral Res 85(1):295-302 (2010)
291	2010	Novel approaches to inhibiting HIV-1 replication.	+	-	nl	Antiviral Res 85(1):119-41 (2010)
292	2010	Development of topical microbicides to prevent the sexual transmission of HIV.	+	-	nl	Antiviral Res 85(1):142-58 (2010)
293	2008	The structural biology of HIV assembly.	+	-	nl	Curr Opin Struct Biol 18(2):203-17 (2008)
294	2009	Peptides in the treatment of AIDS.	+	-	nl	Curr Opin Struct Biol 19(4):473-82 (2009)
295	2010	Chromatin dynamics associated with HIV-1 Tat-activated transcription.	+	-	nl	Biochim Biophys Acta 1799(3-4):275-85 (2010)
296	2011	Seek and treat: HIV update 2011.	+	-	nl	Cleve Clin J Med 78(2):95-100 (2011)
297	2007	Viral infections and the kidney: HIV, hepatitis B, and hepatitis C.	+	-	nl	Cleve Clin J Med 74(5):353-60 (2007)
298	2005	Dyslipidemia in HIV patients.	+	-	nl	Cleve Clin J Med 72(12):1113-20 (2005)
299	2011	Squamous cell carcinoma of the anus-an opportunistic cancer in HIV-positive male homosexuals.	+	-	nl	World J Gastroenterol 17(25):2987-91 (2011)
300	2011	Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals.	+	-	nl	World J Gastroenterol 17(14):1807-16 (2011)
301	2009	Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review.	+	-	nl	World J Gastroenterol 15(30):3713-24 (2009)
302	2009	Transgenic and infectious animal models of HIV-associated nephropathy.	+	-	nl	J Am Soc Nephrol 20(11):2296-304 (2009)
303	2007	Acute renal failure in HIV patients.	+	-	nl	Nephrol Dial Transplant 22(10):2757-62 (2007)
304	2009	Taking a hard look at the pathogenesis of childhood HIV-associated nephropathy.	+	-	nl	Pediatr Nephrol 24(11):2109-19 (2009)
305	2002	Cardiovascular manifestations of HIV infection.	+	-	nl	Circulation 106(11):1420-5 (2002)
306	2005	What a cardiologist needs to know about patients with human immunodeficiency virus infection.	+	-	nl	Circulation 112(25):3947-57 (2005)
307	2006	Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus.	+	-	nl	Clin Infect Dis 42(1):126-31 (2006)
308	2006	HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.	+	-	nl	Clin Infect Dis 42(10):1488-95 (2006)
309	2002	Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature.	+	-	nl	Clin Infect Dis 34(6):838-46 (2002)
310	2002	Focal neurological disease in patients with acquired immunodeficiency syndrome.	+	-	nl	Clin Infect Dis 34(1):103-15 (2002)
311	2002	Clinical indicators of immune restoration following highly active antiretroviral therapy.	+	-	nl	Clin Infect Dis 34(2):224-33 (2002)
312	2002	Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus.	+	-	nl	Clin Infect Dis 34(2):248-59 (2002)
313	2010	HIV-associated tuberculosis: clinical update.	+	-	nl	Clin Infect Dis 50(10):1377-86 (2010)
314	2010	The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity.	+	-	nl	Clin Infect Dis 50 Suppl 3(-):S208-14 (2010)
315	2010	Prevention of tuberculosis in people living with HIV.	+	-	nl	Clin Infect Dis 50 Suppl 3(-):S215-22 (2010)
316	2010	HIV infection-related tuberculosis: clinical manifestations and treatment.	+	-	nl	Clin Infect Dis 50 Suppl 3(-):S223-30 (2010)
317	2007	Tipranavir: a new option for the treatment of drug-resistant HIV infection.	+	-	nl	Clin Infect Dis 45(6):761-9 (2007)
318	2007	Epidemiologic investigation of a cluster of workplace HIV infections in the adult film industry: Los Angeles, California, 2004.	+	-	nl	Clin Infect Dis 44(2):301-5 (2007)
319	2007	Dysregulated energy expenditure in HIV-infected patients: a mechanistic review.	+	-	nl	Clin Infect Dis 44(11):1509-17 (2007)
320	2009	Single-dose nevirapine to prevent mother-to-child transmission of HIV type 1: balancing the benefits and risks.	+	-	nl	Clin Infect Dis 48(4):473-5 (2009)
321	2009	Has human immunodeficiency virus become more virulent?	+	-	nl	Clin Infect Dis 48(9):1293-5 (2009)
322	2009	Are all subtypes created equal? The effectiveness of antiretroviral therapy against non-subtype B HIV-1.	+	-	nl	Clin Infect Dis 48(9):1306-9 (2009)
323	2008	Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS.	+	-	nl	Clin Infect Dis 46(6):e56-60 (2008)
324	2008	Do Vgamma2Vdelta2 T cells influence HIV disease progression?	+	-	nl	Clin Infect Dis 46(9):1473-5 (2008) Nunnari G
325	2009	HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.	+	-	nl	Clin Infect Dis 48(2):214-21 (2009)
326	2009	HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal.	+	-	nl	Clin Infect Dis 48(1):101-7 (2009)
327	2006	Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review.	+	-	nl	Clin Infect Dis 43(2):223-33 (2006)
328	2005	HIV-1 infection and AIDS: consequences for the central nervous system.	+	-	nl	Cell Death Differ 12 Suppl 1(-):878-92 (2005)
329	2005	Cell death in HIV dementia.	+	-	nl	Cell Death Differ 12 Suppl 1(-):893-904 (2005)
330	2009	Biochemical basis of immunological and retroviral responses to DNA-targeted cytosine deamination by activation-induced cytidine deaminase and APOBEC3G.	+	-	nl	J Biol Chem 284(41):27761-5 (2009)
331	2011	Treatment Considerations in Painful HIV-Related Neuropathy.	+	-	nl	Pain Physician 14(6):E505-24 (2011)
332	2008	Approach to the human immunodeficiency virus-infected patient with lipodystrophy.	+	-	nl	J Clin Endocrinol Metab 93(8):2937-45 (2008)
333	2004	Metabolic bone disease in human immunodeficiency virus-infected children.	+	-	nl	J Clin Endocrinol Metab 89(1):21-3 (2004)
334	2009	Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?	+	-	nl	J Clin Endocrinol Metab 94(4):1089-91 (2009) Mantzoros CS
335	2009	HIV-associated lymphomas and gamma-herpesviruses.	+	-	nl	Blood 113(6):1213-24 (2009)
336	2011	HIV and bone metabolism.	+	-	nl	Discov Med 11(60):385-93 (2011)
337	2011	The role of glycosphingolipids in HIV/AIDS.	+	-	nl	Discov Med 11(59):303-13 (2011)
338	2008	Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis.	+	-	nl	Cell Mol Life Sci 65(20):3134-44 (2008)
339	2008	The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.	+	-	nl	J Clin Invest 118(4):1244-54 (2008)
340	2010	Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis.	+	-	nl	PLoS One 5(2):e9119 (2010)
341	2010	Autophagy and HIV.	+	-	nl	Semin Cell Dev Biol 21(7):712-8 (2010)
342	2009	Reversal of HIV-1 latency with anti-microRNA inhibitors.	+	-	nl	Int J Biochem Cell Biol 41(3):451-4 (2009)
343	2007	Autophagy and CD4+ T lymphocyte destruction by HIV-1.	+	-	nl	Autophagy 3(1):32-4 (2007)
344	2008	What is the role of autophagy in HIV-1 infection?	+	-	nl	Autophagy 4(3):273-5 (2008)
345	2002	Selected metabolic and morphologic complications associated with highly active antiretroviral therapy.	+	-	nl	J Infect Dis 185 Suppl 2(-):S123-7 (2002)
346	2011	HIV-1 integrase inhibitor resistance and its clinical implications.	+	-	nl	J Infect Dis 203(9):1204-14 (2011)
347	2010	Clinical management of acute HIV infection: best practice remains unknown.	+	-	nl	J Infect Dis 202 Suppl 2(-):S278-88 (2010)
348	2010	HIV-1 transmission biology: selection and characteristics of infecting viruses.	+	-	nl	J Infect Dis 202 Suppl 2(-):S289-96 (2010)
349	2010	Innate immune activation in primary HIV-1 infection.	+	-	nl	J Infect Dis 202 Suppl 2(-):S297-301 (2010)
350	2010	T cell immunity in acute HIV-1 infection.	+	-	nl	J Infect Dis 202 Suppl 2(-):S302-8 (2010)
351	2010	Viral evolution and escape during acute HIV-1 infection.	+	-	nl	J Infect Dis 202 Suppl 2(-):S309-14 (2010)
352	2010	The humoral response to HIV-1: new insights, renewed focus.	+	-	nl	J Infect Dis 202 Suppl 2(-):S315-22 (2010)
353	2010	Immune responses to HIV vaccines and potential impact on control of acute HIV-1 infection.	+	-	nl	J Infect Dis 202 Suppl 2(-):S323-6 (2010)
354	2010	Rescue of severely immunocompromised HIV-positive persons.	+	-	nl	J Infect Dis 202(10):1467-9 (2010)
355	2010	The detection of acute HIV infection.	+	-	nl	J Infect Dis 202 Suppl 2(-):S270-7 (2010)
356	2010	HIV neutralizing antibodies: clinical correlates and implications for vaccines.	+	-	nl	J Infect Dis 201(7):981-3 (2010) Doria-Rose NA
357	2010	A novel use for an old drug: the potential for minocycline as anti-HIV adjuvant therapy.	+	-	nl	J Infect Dis 201(8):1115-7 (2010) Copeland KF
358	2010	Maraviroc for treatment-naive patients with HIV-1 infection: is the glass half empty or half full?	+	-	nl	J Infect Dis 201(6):797-9 (2010) Sax PE
359	2007	Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.	+	-	nl	J Infect Dis 196 Suppl 1(-):S63-75 (2007)
360	2011	Converging strategies in expression of human complex retroviruses.	+	-	nl	Viruses 3(8):1395-414 (2011)
361	2011	The natural killer cell cytotoxic function is modulated by HIV-1 accessory proteins.	+	-	nl	Viruses 3(7):1091-111 (2011)
362	2011	Innate antiviral response: role in HIV-1 infection.	+	-	nl	Viruses 3(7):1179-203 (2011)
363	2011	CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis.	+	-	nl	Viruses 3(5):586-612 (2011)
364	2011	How HIV takes advantage of the cytoskeleton in entry and replication.	+	-	nl	Viruses 3(4):293-311 (2011)
365	2011	Clinical management of HIV drug resistance.	+	-	nl	Viruses 3(4):347-78 (2011)
366	2011	Rev variation during persistent lentivirus infection.	+	-	nl	Viruses 3(1):1-11 (2011)
367	2011	How HIV-1 takes advantage of the cytoskeleton during replication and cell-to-cell transmission.	+	-	nl	Viruses 3(9):1757-76 (2011)
368	2010	HIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide Substrate.	+	-	nl	Viruses 2(4):880-99 (2010)
369	2010	HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors.	+	-	nl	Viruses 2(4):900-26 (2010)
370	2010	HIV-1 Entry, Inhibitors, and Resistance.	+	-	nl	Viruses 2(5):1069-105 (2010)
371	2010	HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse.	+	-	nl	Viruses 2(5):1239-60 (2010)
372	2010	HIV Genetic Diversity and Drug Resistance.	+	-	nl	Viruses 2(2):503-31 (2010)
373	2007	Epidemiology of human immunodeficiency virus in the United States.	+	-	nl	Clin Microbiol Rev 20(3):478-88, table of contents (2007)
374	2009	Advances and failures in preventing perinatal human immunodeficiency virus infection.	+	-	nl	Clin Microbiol Rev 22(3):493-507 (2009)
375	2005	AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.	+	-	nl	Oncologist 10(6):412-26 (2005)
376	2010	Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.	+	-	nl	RNA Biol 7(6):754-74 (2010)
377	2008	Rheumatic conditions in human immunodeficiency virus infection.	+	-	nl	Rheumatology (Oxford) 47(7):952-9 (2008)
378	2002	HIV associated thrombotic microangiopathy.	+	-	nl	Postgrad Med J 78(923):520-5 (2002)
379	2004	Acquired immunodeficiency syndrome: manifestations in the oral cavity.	+	-	nl	Med Oral Patol Oral Cir Bucal 9 Suppl(-):153-7; 148-53 (2004)
380	2008	Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.	+	-	nl	Med Oral Patol Oral Cir Bucal 13(2):E85-93 (2008)
381	2005	Clinical practice. Management of newly diagnosed HIV infection.	+	-	nl	N Engl J Med 353(16):1702-10 (2005)
382	2004	Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.	+	-	nl	N Engl J Med 350(18):1850-61 (2004)
383	2009	Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.	+	-	nl	N Engl J Med 361(23):2230-40 (2009)
384	2008	The challenge of HIV-1 subtype diversity.	+	-	nl	N Engl J Med 358(15):1590-602 (2008)
385	2009	Clinical practice. Postexposure prophylaxis for HIV infection.	+	-	nl	N Engl J Med 361(18):1768-75 (2009)
386	2010	The treatment of patients with HIV.	+	-	nl	Dtsch Arztebl Int 107(28-29):507-15; quiz 516 (2010)
387	2003	Mechanisms of lipid elevations associated with the treatment of patients with HIV infection.	+	-	nl	MedGenMed 5(2):1 (2003)
388	2008	HIV infection.	+	-	nl	Clin Evid (Online) 2008(-):- (2008)
389	2008	HIV: mother-to-child transmission.	+	-	nl	Clin Evid (Online) 2008(-):- (2008)
390	2008	A 39-year-old man with HIV-associated lipodystrophy.	+	-	nl	JAMA 300(9):1056-66 (2008)
391	2008	Factors influencing the natural history of HIV-1 infection.	+	-	nl	Chin Med J (Engl) 121(24):2613-21 (2008)
392	2005	Low-cost monitoring of HIV infected individuals on highly active antiretroviral therapy (HAART) in developing countries.	+	-	nl	Indian J Med Res 121(4):345-55 (2005)
393	2005	Human immunodeficiency virus (HIV) & sexually transmitted diseases (STDs).	+	-	nl	Indian J Med Res 121(4):369-76 (2005)
394	2005	Clinical profile of HIV in India.	+	-	nl	Indian J Med Res 121(4):377-94 (2005)
395	2005	Progress in diagnosis of opportunistic infections in HIV/AIDS.	+	-	nl	Indian J Med Res 121(4):395-406 (2005)
396	2005	Diagnosis & management of leishmania/HIV co-infection.	+	-	nl	Indian J Med Res 121(4):407-14 (2005)
397	2005	Preventive therapy for tuberculosis in HIV infected individuals.	+	-	nl	Indian J Med Res 121(4):415-23 (2005)
398	2005	Hepatitis B & hepatitis C in HIV-infection.	+	-	nl	Indian J Med Res 121(4):424-50 (2005)
399	2005	Prevention of mother-to-child transmission of HIV--an overview.	+	-	nl	Indian J Med Res 121(4):489-501 (2005)
400	2005	HIV testing technologies after two decades of evolution.	+	-	nl	Indian J Med Res 121(4):519-38 (2005)
401	2005	CD4+ T cell count as a tool to monitor HIV progression & anti-retroviral therapy.	+	-	nl	Indian J Med Res 121(4):539-49 (2005)
402	2005	HIV-TB co-infection: epidemiology, diagnosis & management.	+	-	nl	Indian J Med Res 121(4):550-67 (2005)
403	2009	Cellular & molecular basis of HIV-associated neuropathogenesis.	+	-	nl	Indian J Med Res 129(6):637-51 (2009)
404	2010	Mucocutaneous manifestations in children with human immunodeficiency virus infection.	+	-	nl	Indian J Dermatol Venereol Leprol 76(5):458-66 (2010)
405	2006	Western blot profile in HIV infection.	+	-	nl	Indian J Dermatol Venereol Leprol 72(5):357-60 (2006)
406	2010	Immune reconstitution inflammatory syndrome after initiation of highly active anti-retroviral therapy in HIV/AIDS.	+	-	nl	Indian J Dermatol Venereol Leprol 76(3):301-4 (2010)
407	2004	The neurology of HIV infection.	+	-	nl	J Neurol Neurosurg Psychiatry 75 Suppl 1(-):i29-35 (2004)
408	2007	Re-mapping the molecular features of the human immunodeficiency virus type 1 and human T-cell lymphotropic virus type 1 Brazilian sequences using a bioinformatics unit established in Salvador, Bahia, Brazil, to give support to the viral epidemiology studies.	+	-	nl	Mem Inst Oswaldo Cruz 102(2):133-9 (2007)
409	2011	Impact of current antiretroviral therapies on neuroAIDS.	+	-	nl	Expert Rev Anti Infect Ther 9(4):371-4 (2011)
410	2010	First real success for anti-HIV gel: a new start for HIV microbicides?	+	-	nl	Future Microbiol 5(11):1621-3 (2010)
411	2010	Protease inhibitor-based antiretroviral therapy in treatment-naive HIV-1-infected patients: the evidence behind the options.	+	-	nl	J Antimicrob Chemother 65(6):1094-9 (2010)
412	2009	Eradication of HIV: current challenges and new directions.	+	-	nl	J Antimicrob Chemother 63(1):7-10 (2009)
413	2009	Using HIV resistance tests in clinical practice.	+	-	nl	J Antimicrob Chemother 64(2):218-22 (2009)
414	2008	HIV and mitochondrial toxicity in children.	+	-	nl	J Antimicrob Chemother 61(1):8-12 (2008)
415	2005	Current perspectives on HIV-associated lipodystrophy syndrome.	+	-	nl	J Antimicrob Chemother 56(1):6-9 (2005)
416	2011	The discovery and development of HIV therapy: the new challenges.	+	-	nl	Ann Ist Super Sanita 47(1):41-3 (2011)
417	2011	A brief history of antiretroviral therapy of HIV infection: success and challenges.	+	-	nl	Ann Ist Super Sanita 47(1):44-8 (2011)
418	2010	HIV virology and pathogenetic mechanisms of infection: a brief overview.	+	-	nl	Ann Ist Super Sanita 46(1):5-14 (2010)
419	2010	Laboratory diagnostics for HIV infection.	+	-	nl	Ann Ist Super Sanita 46(1):24-33 (2010)
420	2010	Suggested strategies for the laboratory diagnosis of HIV infection in Italy.	+	-	nl	Ann Ist Super Sanita 46(1):34-41 (2010)
421	2006	Advances in antiretroviral therapy.	+	-	nl	Top HIV Med 14(1):36-62 (2006)
422	2006	Complications of HIV disease and antiretroviral therapy.	+	-	nl	Top HIV Med 14(1):27-35 (2006)
423	2006	Neurologic complications of HIV disease and their treatments.	+	-	nl	Top HIV Med 14(1):21-6 (2006)
424	2010	Advances in basic science.	+	-	nl	Top HIV Med 18(2):28-34 (2010)
425	2010	HIV epidemiology, testing strategies, and prevention interventions.	+	-	nl	Top HIV Med 18(2):38-44 (2010)
426	2010	Neurologic complications of HIV disease and their treatment.	+	-	nl	Top HIV Med 18(2):45-55 (2010)
427	2010	Complications of HIV disease and antiretroviral treatment.	+	-	nl	Top HIV Med 18(2):57-65 (2010)
428	2010	Advances in antiretroviral therapy.	+	-	nl	Top HIV Med 18(2):66-92 (2010)
429	2005	Antiretroviral drug resistance and resistance testing.	+	-	nl	Top HIV Med 13(5):138-42 (2005)
430	2005	Oral manifestations of HIV disease.	+	-	nl	Top HIV Med 13(5):143-8 (2005)
431	2005	Dermatologic manifestations of HIV infection.	+	-	nl	Top HIV Med 13(5):149-54 (2005)
432	2009	HIV-associated resources on the internet.	+	-	nl	Top HIV Med 17(5):151-62 (2009)
433	2003	Drug resistance mutations in HIV-1.	+	-	nl	Top HIV Med 11(6):215-21 (2003)
434	2003	Advances in antiretroviral therapy.	+	-	nl	Top HIV Med 11(3):97-127 (2003)
435	2008	Update of the Drug Resistance Mutations in HIV-1.	+	-	nl	Top HIV Med 16(5):138-45 (2008)
436	2008	Drug-drug interactions with newer antiretroviral agents.	+	-	nl	Top HIV Med 16(5):146-50 (2008)
437	2010	Dermatologic manifestations of HIV in Africa.	+	-	nl	Top HIV Med 18(1):16-22 (2010)
438	2010	Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation.	+	-	nl	Top HIV Med 18(1):2-6 (2010)
439	2007	HIV disease progression: immune activation, microbes, and a leaky gut.	+	-	nl	Top HIV Med 15(4):114-7 (2007)
440	2007	Update of the drug resistance mutations in HIV-1: 2007.	+	-	nl	Top HIV Med 15(4):119-25 (2007)
441	2007	Neurologic complications of HIV disease and their treatment.	+	-	nl	Top HIV Med 15(2):32-9 (2007)
442	2007	Complications of HIV disease and therapy.	+	-	nl	Top HIV Med 15(2):40-7 (2007)
443	2007	Advances in antiretroviral therapy.	+	-	nl	Top HIV Med 15(2):48-82 (2007)
444	2005	Complications of HIV disease and antiretroviral therapy.	+	-	nl	Top HIV Med 13(1):16-23 (2005)
445	2005	Advances in antiretroviral therapy.	+	-	nl	Top HIV Med 13(1):24-44 (2005)
446	2009	Neurologic complications of HIV disease and their treatment.	+	-	nl	Top HIV Med 17(2):46-56 (2009)
447	2009	Complications of HIV disease and antiretroviral therapy.	+	-	nl	Top HIV Med 17(2):57-67 (2009)
448	2009	Advances in antiretroviral therapy.	+	-	nl	Top HIV Med 17(2):68-88 (2009)
449	2008	Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy.	+	-	nl	Top HIV Med 16(1):31-60 (2008)
450	2008	Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Complications of HIV disease and therapy.	+	-	nl	Top HIV Med 16(1):23-30 (2008)
451	2008	Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Neurologic complications of HIV disease and their treatment.	+	-	nl	Top HIV Med 16(1):15-22 (2008)
452	2008	Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. HIV testing and prevention strategies.	+	-	nl	Top HIV Med 16(1):9-14 (2008)
453	2008	Pathogenesis and treatment of lipodystrophy: what clinicians need to know.	+	-	nl	Top HIV Med 16(4):127-33 (2008)
454	2008	Non--AIDS-defining malignancies in HIV.	+	-	nl	Top HIV Med 16(4):117-21 (2008)
455	2008	Emerging resistance profiles of newly approved antiretroviral drugs.	+	-	nl	Top HIV Med 16(4):110-6 (2008)
456	2005	Selected rare, noninfectious syndromes associated with HIV infection.	+	-	nl	Top HIV Med 13(2):75-8 (2005)
457	2005	Metabolic complications of antiretroviral therapy.	+	-	nl	Top HIV Med 13(2):70-4 (2005)
458	2005	HIV in adolescents and young adults: half of all new infections in the United States.	+	-	nl	Top HIV Med 13(3):101-5 (2005)
459	2009	Update on cardiovascular complications in HIV infection.	+	-	nl	Top HIV Med 17(3):98-103 (2009)
460	2006	Human immunodeficiency virus infection and macrophage cholesterol metabolism.	+	-	nl	J Leukoc Biol 80(5):1044-51 (2006)
461	2006	Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases.	+	-	nl	J Leukoc Biol 80(5):1052-66 (2006)
462	2006	HIV accomplices and adversaries in macrophage infection.	+	-	nl	J Leukoc Biol 80(5):973-83 (2006)
463	2010	The macrophage: the intersection between HIV infection and atherosclerosis.	+	-	nl	J Leukoc Biol 87(4):589-98 (2010)
464	2010	Macrophage polarization and HIV-1 infection.	+	-	nl	J Leukoc Biol 87(4):599-608 (2010)
465	2010	The role of macrophages in the development and progression of AIDS-related non-Hodgkin lymphoma.	+	-	nl	J Leukoc Biol 87(4):627-32 (2010)
466	2010	HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.	+	-	nl	J Leukoc Biol 87(4):621-6 (2010)
467	2010	Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.	+	-	nl	J Leukoc Biol 87(4):609-20 (2010)
468	2010	Macrophages: do they impact AIDS progression more than CD4 T cells?	+	-	nl	J Leukoc Biol 87(4):569-73 (2010)
469	2010	HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.	+	-	nl	J Leukoc Biol 87(4):575-88 (2010)
470	2002	Prospects for immune reconstitution in HIV-1 infection.	+	-	nl	Clin Exp Immunol 127(3):402-11 (2002)
471	2007	HIV infection and lymphoma.	+	-	nl	J Clin Pathol 60(12):1365-72 (2007)
472	2008	The lymph node in HIV pathogenesis.	+	-	nl	Semin Immunol 20(3):187-95 (2008)
473	2008	The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche.	+	-	nl	Semin Immunol 20(3):181-6 (2008)
474	2008	Roles of MCP-1 in development of HIV-dementia.	+	-	nl	Front Biosci 13(-):3913-8 (2008)
475	2011	Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir.	+	-	nl	Mol Med 17(5-6):466-72 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.